CNTX
Context Therapeutics
$0.20
−$0.01 (−4.27%)Oct 29, 2026
Key metrics
The numbers that frame CNTX today
- Market cap
- $18.56M
- ROIC
- 1,191.4%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.20
- 52wk High
- $3.62
Growth
Revenue and earnings trend for CNTX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CNTX
Is Context Therapeutics a good buy?
No. Context Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case.
What is the market capitalization of CNTX?
Context Therapeutics's market capitalization is $18.56M.
What is the 52-week high for CNTX stock?
The 52-week high for Context Therapeutics is $3.62. The current close of $0.20 is 94.4% below that high.
What is the 52-week low for CNTX stock?
The 52-week low for Context Therapeutics is $0.20. The current close of $0.20 is 1% above that low.
Does CNTX stock pay dividends?
Context Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CNTX?
Context Therapeutics's Debt / Equity ratio is 0.01.